200 related articles for article (PubMed ID: 36060673)
1. Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment.
Liu Y; Lin J; Chen L; Mao X; Wang L; Chen Q; Yu S; Kuang Y
Front Physiol; 2022; 13():965210. PubMed ID: 36060673
[No Abstract] [Full Text] [Related]
2. Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment.
Liu Y; Lin J; Shen X; Zhu Q; Kuang Y
Front Endocrinol (Lausanne); 2023; 14():1072170. PubMed ID: 36936138
[TBL] [Abstract][Full Text] [Related]
3. Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study.
Huang J; Xie Q; Lin J; Lu X; Zhu J; Gao H; Cai R; Kuang Y
Drug Des Devel Ther; 2019; 13():4461-4470. PubMed ID: 32099323
[TBL] [Abstract][Full Text] [Related]
4. The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study.
Zhang Y; Li H; Zhu S; Jiang S; Zhao W; Wang X; Tian L; Zhao G; He N; Diao H; Cao H; Zhang C
Front Endocrinol (Lausanne); 2023; 14():1295787. PubMed ID: 38155955
[TBL] [Abstract][Full Text] [Related]
5. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
6. Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome.
Ye H; Tian H; He W; Lyu Q; Kuang Y; Chen Q; Sun L
Reprod Biol Endocrinol; 2018 May; 16(1):53. PubMed ID: 29807533
[TBL] [Abstract][Full Text] [Related]
7. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.
Dong J; Wang Y; Chai WR; Hong QQ; Wang NL; Sun LH; Long H; Wang L; Tian H; Lyu QF; Lu XF; Chen QJ; Kuang YP
BJOG; 2017 Jun; 124(7):1048-1055. PubMed ID: 28276192
[TBL] [Abstract][Full Text] [Related]
8. Progestin-primed ovarian stimulation protocol with or without letrozole for patients with normal ovarian reserve: a retrospective cohort study.
Jiang X; Jiang S; Diao H; Deng K; Zhang C
J Clin Pharm Ther; 2022 Apr; 47(4):469-476. PubMed ID: 34796515
[TBL] [Abstract][Full Text] [Related]
9. Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
Wang Y; Chen Q; Wang N; Chen H; Lyu Q; Kuang Y
Medicine (Baltimore); 2016 Mar; 95(9):e2939. PubMed ID: 26945402
[TBL] [Abstract][Full Text] [Related]
10. Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol.
Huang TC; Huang MZ; Seow KM; Yang IJ; Pan SP; Chen MJ; Hwang JL; Chen SU
Sci Rep; 2021 Nov; 11(1):22732. PubMed ID: 34815477
[TBL] [Abstract][Full Text] [Related]
11. Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization/intracytoplasmic sperm injection: A prospective randomized controlled trial.
Liu Y; Chen Q; Yu S; Wang Y; He W; Chang HY; Wang B; Gao H; Long H; Wang L; Lyu Q; Ai A; Kuang Y
Clin Endocrinol (Oxf); 2018 Mar; 88(3):442-452. PubMed ID: 29247457
[TBL] [Abstract][Full Text] [Related]
12. Letrozole cotreatment progestin-primed ovarian stimulation in women undergoing controlled ovarian stimulation for in vitro fertilization.
Wang X; Zhang Y; Diao H; Jiang S; Zhang C
J Obstet Gynaecol Res; 2024 May; 50(5):890-898. PubMed ID: 38403851
[TBL] [Abstract][Full Text] [Related]
13. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing
Yang L; Liang F; Yuan Y; Luo X; Wang Q; Yao L; Zhang X
Front Endocrinol (Lausanne); 2023; 14():1224858. PubMed ID: 37795363
[TBL] [Abstract][Full Text] [Related]
15. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
Tu X; You B; Jing M; Lin C; Zhang R
Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
[TBL] [Abstract][Full Text] [Related]
16. The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments.
Zhu X; Ye H; Fu Y
Medicine (Baltimore); 2016 Jul; 95(28):e4193. PubMed ID: 27428219
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response.
Zhang J; Du M; Li Z; Liu W; Ren B; Zhang Y; Guan Y
Front Endocrinol (Lausanne); 2021; 12():708704. PubMed ID: 34630325
[TBL] [Abstract][Full Text] [Related]
18. Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent
Chen C; Yu S; Yu W; Yan Z; Jin W; Si J; Li M; Cai R; Li D; Wang L; Chen Q; Kuang Y; Lyu Q; Long H
Front Physiol; 2021; 12():744968. PubMed ID: 35222055
[TBL] [Abstract][Full Text] [Related]
19. Progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in women with polycystic ovarian syndrome undergoing
Zhu X; Ye H; Ye J; Fu Y
Ann Transl Med; 2021 Mar; 9(5):387. PubMed ID: 33842608
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.
Kalafat E; Turkgeldi E; Yıldız S; Dizdar M; Keles I; Ata B
Front Endocrinol (Lausanne); 2022; 13():837880. PubMed ID: 35663329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]